ScoreWhy is Anlon Healthcare Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.81 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 65.60% and Operating profit at 0%
3
The company has declared Positive results for the last 2 consecutive quarters
- PAT(9M) Higher at Rs 24.26 Cr
- NET SALES(Q) Highest at Rs 55.42 cr
4
With ROE of 13, it has a Very Expensive valuation with a 3.4 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 36%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Anlon Healthcare should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.24
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
31.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.92%
ROCE (avg)
9.07%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
33
Price to Book Value
3.41
EV to EBIT
16.63
EV to EBITDA
16.14
EV to Capital Employed
3.25
EV to Sales
4.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.57%
ROE (Latest)
12.98%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
PAT(9M)
Higher at Rs 24.26 Cr
NET SALES(Q)
Highest at Rs 55.42 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Anlon Healthcare
Profit After Tax (PAT) - Nine Monthly
At Rs 24.26 cr has Grown at 44.84%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 55.42 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 55.42 cr has Grown at 30.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 42.50 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 24.26 Cr
than preceding 12 month period ended Mar 2026 of Rs 20.30 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
